Why Purchase a Cancer Insurance Policy? The American Cancer Society estimated there would be more than 1.7 million new cancer cases diagnosed in 2019. Approximately 39 out of 100 men and 38 out of 100 women will develop cancer during their lifetime. According to the Agency for Healthcare Research and Quality, the direct medical costs for cancer were an estimated $80.2 billion in 2015. Of those costs, 52% were for hospital outpatient or office-based provider visits, and 38% were for inpatient hospital stays. These report estimates are based on individual cases, but the reality is cancer affects entire households, not just an individual. Extended time off work, family members becoming caregivers, outside caregiver expenses, medical bills - cancer affects us physically, emotionally, and financially. Cancer insurance policies can help keep the out-of-pocket costs down so that you can focus on what matters most to you. What is a Cancer Insurance Policy? A cancer insurance policy can provide coverage for services major medical plans may not cover. What Cancer Insurance Policy Solutions does ManhattanLife Offer? ManhattanLife offers “Cancer First Occurrence” and “Cancer Care Plus” insurance. Cancer Care Plus and Specified Disease Insurance Benefits Guaranteed Renewable for Life Cancer screening test First Occurrence Benefit Rider Daily Hospital Confinement Benefit Surgical Benefit Radiation and Chemotherapy Hospital and Other Care Facility Benefits Optional Intensive Care Unit and Critical Care Benefit Riders* Cancer First Occurrence Insurance Benefits Guaranteed Renewable for Life Payment is made directly to you upon an initial cancer diagnosis Choose a benefit amount up to $50,000 Family Plan option – pays the same FOB benefit for each covered family member Optional Intensive Unit Care and Cancer Screening Benefit Riders* *Optional benefit riders have state variations and may not be available in all states This estimate is from the American Cancer Society’s “Cancer Facts & Figures 2019” and includes all cancer types except basal cell and squamous cell skin cancers and in situ carcinomas except urinary bladder. These estimates are based on a set of large-scale surveys of individuals and their medical providers called the Medical Expenditure Panel Survey, the most complete, nationally representative data on health care and expenditures. Visit Medical Expenditure Panel Survey (MEPS) for more information. Learn more about Manhattanlife's Cancer Insurance Policies .